Federal Court Denies Arbitration and Allows Oral Tirzepatide Class Action to Proceed

A federal judge in Pennsylvania has ruled that a consumer class action over the sale of “oral tirzepatide,” a pill marketed as a weight-loss alternative to injectable GLP-1 drugs, will move forward in court.

On November 18, 2026, Chief Judge Matthew W. Brann of the U.S. District Court for the Middle District of Pennsylvania largely denied the defendants’ motions to dismiss in Freeland v. Foothills Professional Pharmacy, Ltd., No. 4:26-cv-00263. The Court also denied the defendants’ motions to compel arbitration, so the case will stay in federal court and proceed as a class action.

The lawsuit was filed by Chimicles Schwartz Kriner & Donaldson-Smith LLP on behalf of Cynthia Freeland and a proposed class of consumers nationwide. The complaint alleges that consumers were misled into buying oral tirzepatide and that a compounding pharmacy, a telehealth technology company, a clinician network, and a physician worked together to market and sell the pills nationwide. It asserts claims under the federal Racketeer Influenced and Corrupt Organizations Act (RICO) and state statutory and common law.

Among other things, the Court held:

  • No arbitration. Clicking “Continue” at checkout did not bind consumers to arbitrate, because no reasonable reader would understand “continue” to mean “agree.”
  • Federal drug law does not bar the claims. The fraud claims do not depend on federal drug regulation: “a promise that a product works, made about a product that does not, is fraud with or without the FDCA.”
  • RICO claims proceed. The complaint adequately alleges a coordinated scheme under RICO.

The Court’s ruling narrowed the case on two discrete points. It dismissed, without prejudice, claims brought on behalf of a proposed subclass of consumers in fourteen other states, and it limited one theory under Pennsylvania’s consumer protection law. Claims for violations of RICO, Pennsylvania’s Unfair Trade Practices and Consumer Protection Law, fraud, and unjust enrichment will proceed.

A copy of the Court’s Memorandum Opinion can be accessed here: [Memorandum Opinion (Dkt. #89)]

Attorneys for this case:

Nicholas E. Chimicles
Kimberly Donaldson-Smith
Dylan D. Altland
Holly E. Jones